Altre lingue Themis Medicare Limited

Azioni

THEMISMED

INE083B01024

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:48 10/05/2024			Variaz. 5gg	Var. 1 gen.
208,6 ^INR	+0,31%		-4,18%	-2,00%

10/02	Themis Medicare Limited riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 dicembre 2023	CI
2023	Themis Medicare Limited lancia REMITHEM	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	10/02
Themis Medicare Limited Launches REMITHEM	10/11
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04/11
Themis Medicare Limited Announces Incorporation of Wholly Owned Subsidiary	20/09/23
Themis Medicare Limited Announces Cessation of Vijay Agarwal as Independent Director	09/09/23
Themis Medicare Limited Appoints Reena Patel as Alternate Non-Executive Non- Non-Independent Director to Dr. Adam Demeter, Effective September 11, 2023	07/09/23
Themis Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	13/05/23
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	13/05/23
Themis Medicare Limited Recommends Dividend for Financial Year Ended 31 March 2023	13/05/23
Themis Medicare Limited Announces Board Resignations	02/05/23
Themis Medicare Gets Drug Controller General of India’s No-Objection for Diclofenac Injection	17/02/23
Themis Medicare Announces DCGI Approval of Remifentanil Hydrochloride 1mg/2mg for Injection for Import and Marketing	17/02/23
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03/02/23
Themis Medicare Launches Drug for Treatment of Menopausal Symptoms in India	04/01/23
Themis Medicare Ltd. Launches Lenzetto Â¡Global Brand of Estradiol Novel Drug Delivery System	03/01/23
Themis Medicare Posts Decline in Fiscal Q2 Consolidated Profit	09/11/22
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	07/11/22
Themis Medicare Limited entered into share purchase agreement to acquire additional 6.47% stake in Gujarat Themis Biosyn Limited from Pharmaceutical Business Group Limited for approximately INR 700 million.	07/11/22
Themis Medicare : General updates	31/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Themis Medicare Limited

Azioni

THEMISMED

INE083B01024

Altre lingue

Filtri